litlas
Log inCreate account

Ted Gooley

Active 1994–2025

159
Papers
28,568
Citations
94
h-index
153
i10-index

Citations

Citations per year for Ted Gooley1948: 1 citations1980: 1 citations1995: 7 citations1996: 32 citations1997: 42 citations1998: 68 citations1999: 104 citations2000: 150 citations2001: 162 citations2002: 222 citations2003: 241 citations2004: 163 citations2005: 170 citations2006: 152 citations2007: 200 citations2008: 194 citations2009: 219 citations2010: 170 citations2011: 187 citations2012: 208 citations2013: 218 citations2014: 184 citations2015: 180 citations2016: 190 citations2017: 165 citations2018: 125 citations2019: 627 citations2020: 738 citations2021: 725 citations2022: 555 citations2023: 357 citations2024: 680 citations2025: 295 citations2026: 8 citations1949–1979: no citations, so these years are not shown1981–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,556 citing papers, 30.1% of this breakdownUnited Kingdom: 817 citing papers, 6.9% of this breakdownGermany: 778 citing papers, 6.6% of this breakdownFrance: 688 citing papers, 5.8% of this breakdownItaly: 659 citing papers, 5.6% of this breakdownChina: 475 citing papers, 4% of this breakdownNetherlands: 441 citing papers, 3.8% of this breakdownSpain: 411 citing papers, 3.5% of this breakdownCanada: 405 citing papers, 3.4% of this breakdownJapan: 311 citing papers, 2.6% of this breakdownSwitzerland: 290 citing papers, 2.5% of this breakdownSweden: 254 citing papers, 2.2% of this breakdown
0%30.1%Other 23%

Institutions

Fields

  • Medicine85.3%
  • Immunology and Microbiology7.9%
  • Biochemistry, Genetics and Molecular Biology4.2%
  • Mathematics0.5%
  • Nursing0.3%
  • Psychology0.2%
  • Other1.6%

Topics

  • Hematopoietic Stem Cell Transplantation12.5%
  • CAR-T cell therapy research5.7%
  • Acute Myeloid Leukemia Research5.3%
  • Immune Cell Function and Interaction4.9%
  • Acute Lymphoblastic Leukemia research4.3%
  • T-cell and B-cell Immunology3.7%
  • Other63.6%

Coauthors

All papers

Open in search
  1. HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    Authors: Leo Luznik, Paul V. O’Donnell, Heather J. Symons, Allen Chen, M. Susan Leffell, Marianna Zahurak, Ted Gooley, S Piantadosi, Michele Kaup, Richard F. Ambinder, Carol Ann Huff, William Matsui, Javier Bolaños‐Meade, Ivan Borrello, Jonathan D. Powell, Elizabeth B. Harrington, S. Warnock, Mary E.D. Flowers, Robert A. Brodsky, Brenda M. Sandmaier, Rainer Storb, Richard J. Jones, Ephraim J. Fuchs - Biology of Blood and Marrow Transplantation 2008 cited by 1,906

  2. Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians

    Authors: Jordon Gauthier, Qian Wu, Ted Gooley - Bone Marrow Transplantation 2019 cited by 485

  3. Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy

    Authors: Kevin A. Hay, Jordan Gauthier, Alexandre V. Hirayama, Jenna Voutsinas, Qian Wu, Daniel Li, Ted Gooley, Sindhu Cherian, Xueyan Chen, Barbara S. Pender, Reed M. Hawkins, Aesha Vakil, Rachel N. Steinmetz, Gary Schoch, Aude G. Chapuis, Brian G. Till, Hans‐Peter Kiem, Jorge Ramos, Mazyar Shadman, Ryan D. Cassaday, Utkarsh Acharya, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle - Blood 2019 cited by 401

  4. The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells

    Authors: Alexandre V. Hirayama, Jordan Gauthier, Kevin A. Hay, Jenna Voutsinas, Qian Wu, Ted Gooley, Daniel Li, Sindhu Cherian, Xueyan Chen, Barbara S. Pender, Reed M. Hawkins, Aesha Vakil, Rachel N. Steinmetz, Utkarsh Acharya, Ryan D. Cassaday, Aude G. Chapuis, Tejaswini Dhawale, Paul C. Hendrie, Hans‐Peter Kiem, Ryan C. Lynch, Jorge Ramos, Mazyar Shadman, Brian G. Till, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle - Blood 2019 cited by 336

  5. Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD

    Authors: Benjamin Watkins, Muna Qayed, Courtney McCracken, Brandi Bratrude, Kayla Betz, Yvonne Suessmuth, Alison Yu, Shauna Sinclair, Scott N. Furlan, Steven E. Bosinger, Victor Tkachev, James Rhodes, Audrey G. Tumlin, Alexandria Narayan, Kayla Cribbin, Scott Gillespie, Ted Gooley, Marcelo C. Pasquini, Kyle Hebert, Urvi Kapoor, André Rogatko, Mourad Tighiouart, Sungjin Kim, Catherine Bresee, Sung Won Choi, Jeffrey Davis, Christine Duncan, Roger Giller, Michael Grimley, Andrew C. Harris, David A. Jacobsohn, Nahal Lalefar, Maxim Norkin, Nosha Farhadfar, Michael A. Pulsipher, Shalini Shenoy, Aleksandra Petrović, Kirk R. Schultz, Gregory A. Yanik, Edmund K. Waller, John E. Levine, James L.M. Ferrara, Bruce R. Blazar, Amelia Langston, John Horan, Leslie S. Kean - Journal of Clinical Oncology 2021 cited by 249

  6. γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial

    Authors: Andrew J. Cowan, Margot J. Pont, Blythe Sather, Cameron J. Turtle, Brian G. Till, Edward N. Libby, David G. Coffey, Sherilyn A. Tuazon, Brent L. Wood, Ted Gooley, Vicky Q Wu, Jenna Voutsinas, Xiaoling Song, Mazyar Shadman, Jordan Gauthier, Aude G. Chapuis, Filippo Milano, David G. Maloney, Stanley R. Riddell, Damian J. Green - The Lancet Oncology 2023 cited by 98

  7. T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

    Authors: Aude G. Chapuis, Daniel Egan, Merav Bar, Thomas M. Schmitt, Megan S. McAfee, Kelly G. Paulson, Valentin Voillet, Raphaël Gottardo, Gunnar B. Ragnarsson, Marie Bleakley, Cecilia C.S. Yeung, Petri R. Muhlhauser, Hieu Nguyen, Lara Kropp, Luca Castelli, Felecia Wagener, Daniel Hunter, Marcus Lindberg, Kristen W. Cohen, Aaron Seese, M. Juliana McElrath, Natalie Duerkopp, Ted Gooley, Philip D. Greenberg - Nature Medicine 2019 cited by 322

  8. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

    Authors: Ted Gooley, Wendy M. Leisenring, John Crowley, Barry E. Storer - Statistics in Medicine 1999 cited by 2,676

  9. Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts

    Authors: George B. McDonald, Brenda M. Sandmaier, Marco Mielcarek, Mohamed L. Sorror, Steven A. Pergam, Guang‐Shing Cheng, Sangeeta Hingorani, Michael Boeckh, Mary D. Flowers, Stephanie J. Lee, Frederick R. Appelbaum, Rainer Storb, Paul J. Martin, H. Joachim Deeg, Gary Schoch, Ted Gooley - Annals of Internal Medicine 2020 cited by 278

  10. Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

    Authors: Ted Gooley, Jason W. Chien, Steven A. Pergam, Sangeeta Hingorani, Mohamed L. Sorror, Michael Boeckh, Paul J. Martin, Brenda M. Sandmaier, Kieren A. Marr, Frederick R. Appelbaum, Rainer Storb, George B. McDonald - New England Journal of Medicine 2010 cited by 1,479

  11. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis

    Authors: Thomas Luft, Axel Benner, Sonata Jodele, Christopher E. Dandoy, Rainer Storb, Ted Gooley, Brenda M. Sandmaier, Natália Becker, Aleksandar Radujkovic, Peter Dreger, Olaf Penack - The Lancet Haematology 2017 cited by 246

  12. EASIX and mortality after allogeneic stem cell transplantation

    Authors: Thomas Luft, Axel Benner, Tobias Terzer, Sonata Jodele, Christopher E. Dandoy, Rainer Storb, Lambros Kordelas, Dietrich W. Beelen, Ted Gooley, Brenda M. Sandmaier, Mohamed L. Sorror, Markus Zeisbrich, Aleksandar Radujkovic, Peter Dreger, Olaf Penack - Bone Marrow Transplantation 2019 cited by 160

  13. Cord-Blood Transplantation in Patients with Minimal Residual Disease

    Authors: Filippo Milano, Ted Gooley, Brent L. Wood, Ann E. Woolfrey, Mary E.D. Flowers, K Doney, Robert P. Witherspoon, Marco Mielcarek, Joachim Deeg, Mohamed L. Sorror, Ann Dahlberg, Brenda M. Sandmaier, Rachel B. Salit, Effie W. Petersdorf, Frederick R. Appelbaum, Colleen Delaney - New England Journal of Medicine 2016 cited by 441

  14. Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

    Authors: Roland B. Walter, Ted Gooley, Brent L. Wood, Filippo Milano, Min Fang, Mohamed L. Sorror, Elihu H. Estey, Alexander I. Salter, Emily Lansverk, Jason W. Chien, Ajay K. Gopal, Frederick R. Appelbaum, John M. Pagel - Journal of Clinical Oncology 2011 cited by 399

  15. High HLA-DP Expression and Graft-versus-Host Disease

    Authors: Effie W. Petersdorf, Mari Malkki, Colm Ó’hUigín, Mary Carrington, Ted Gooley, Michael Haagenson, Mary M. Horowitz, Stephen R. Spellman, Tao Wang, Philip A. Stevenson - New England Journal of Medicine 2015 cited by 273

  16. Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy

    Authors: Victor A. Chow, Ajay K. Gopal, David G. Maloney, Cameron J. Turtle, Stephen D. Smith, Chaitra S. Ujjani, Mazyar Shadman, Ryan D. Cassaday, Brian G. Till, Yolanda D. Tseng, Edus H. Warren, Andrei R. Shustov, Manoj Menon, Sandra L Bhark, Utkarsh Acharya, Erin Mullane, Lindsay M. Hannan, Jenna Voutsinas, Ted Gooley, Ryan C. Lynch - American Journal of Hematology 2019 cited by 137

  17. Immune Checkpoint Inhibitor Use in Solid Organ Transplant Recipients: A Systematic Review

    Authors: Andrew J. Portuguese, Scott S. Tykodi, Christopher D. Blosser, Ted Gooley, John A. Thompson, Evan Hall - Journal of the National Comprehensive Cancer Network 2022 cited by 77

  18. EASIX-1year and late mortality after allogeneic stem cell transplantation

    Authors: Lambros Kordelas, Tobias Terzer, Ted Gooley, Chris Davis, Brenda M. Sandmaier, Mohamed L. Sorror, Olaf Penack, Nigel Dross Engelbert Schaeper, Igor Wolfgang Blau, Dietrich W. Beelen, Aleksandar Radujkovic, Peter Dreger, Thomas Luft - Blood Advances 2023 cited by 34

  19. HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1

    Authors: Jeffrey M. Venstrom, Gianfranco Pittari, Ted Gooley, Joseph H. Chewning, Stephen R. Spellman, Michael Haagenson, Meighan M. Gallagher, Mari Malkki, Effie W. Petersdorf, Bo Dupont, Katharine C. Hsu - New England Journal of Medicine 2012 cited by 430

  20. Outcomes of acute leukemia patients transplanted with naive T cell–depleted stem cell grafts

    Authors: Marie Bleakley, Shelly Heimfeld, Keith R. Loeb, Lori Jones, Colette Chaney, Stuart Seropian, Ted Gooley, Franziska Sommermeyer, Stanley R. Riddell, Warren D. Shlomchik - Journal of Clinical Investigation 2015 cited by 270

  21. Fully Human Bcma Targeted Chimeric Antigen Receptor T Cells Administered in a Defined Composition Demonstrate Potency at Low Doses in Advanced Stage High Risk Multiple Myeloma

    Authors: Damian J. Green, Margot J. Pont, Blythe Sather, Andrew J. Cowan, Cameron J. Turtle, Brian G. Till, Anne M Nagengast, Edward N. Libby, Pamela S. Becker, David G. Coffey, Sherilyn A. Tuazon, Brent L. Wood, Michelle Blake, Melissa Works, Bruce S. Thompson, Ted Gooley, Frederick R. Appelbaum, David G. Maloney, Stanley R. Riddell - Blood 2018 cited by 129

  22. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report

    Authors: Zachariah DeFilipp, Daniel R. Couriel, Aleksandr Lazaryan, Vijaya Raj Bhatt, Nataliya P. Buxbaum, Amin M. Alousi, Attilio Olivieri, Dražen Pulanić, Joerg Halter, Lori Henderson, Robert Zeiser, Ted Gooley, Kelli P. A. MacDonald, Daniel Wolff, Kirk R. Schultz, Sophie Paczesny, Yoshihiro Inamoto, Corey Cutler, Carrie L. Kitko, Joseph A. Pidala, Stephanie J. Lee, Gèrard Socié, Stefanie Sarantopoulos, Steven Z. Pavletic, Paul J. Martin, Bruce R. Blazar, Hildegard Greinix - Transplantation and Cellular Therapy 2021 cited by 55

  23. Abstract P2-09-13: A phase I study of adoptive immunotherapy for ROR1+ advanced triple negative breast cancer (TNBC) with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen receptor (ROR1-CAR)

    Authors: JM Specht, Siow Ming Lee, Cameron J. Turtle, Christoph Berger, A Balakrishnan, Shivani Srivastava, V Viollet, Josh Veatch, Ted Gooley, Erin Mullane, CN Chaney, Christoph Rader, RH Pierce, Raphaël Gottardo, DG Maloney, SR Riddell - Cancer Research 2019 cited by 28

  24. Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma

    Authors: Thomas H. Pulliam, Saumya Jani, Lichen Jing, Heeju Ryu, Ana Jojic, Carolyn Shasha, Jiajia Zhang, Rima M. Kulikauskas, Candice D. Church, Charlie Garnett‐Benson, Ted Gooley, Aude G. Chapuis, Kelly G. Paulson, Kellie N. Smith, Drew M. Pardoll, Evan W. Newell, David M. Koelle, Suzanne L. Topalian, Paul Nghiem - Cell Reports Medicine 2024 cited by 25